Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Elica | 7L4 | Jan 29, 2025 | 1.50 | +1.35 |
Elicera Therapeutics AB | 8E8 | Jan 29, 2025 | 0.24 | +22.28 |
ELINOIL HELL.PET.INH. | EL7 | Jan 29, 2025 | 2.15 | -0.46 |
ELIOR GROUP SCA EO -,01 | 21E | Jan 29, 2025 | 2.62 | +0.38 |
Elis SA | 7EL | Jan 29, 2025 | 19.68 | +0.77 |
Elisa | EIA | Jan 29, 2025 | 43.54 | +1.54 |
Elixinol Global Ltd Ordinary Shares (Australia) | E8M | Jan 29, 2025 | 0.02 | +9.30 |
Elixirr International Plc | 54K | Jan 29, 2025 | 8.35 | 0.00 |
Elkem | 1DP | Jan 29, 2025 | 1.81 | +1.06 |
Ell Environmental Holdings Limited | 6EL | Jan 29, 2025 | 0.01 | 0.00 |
Ellaktor S.A | HLL | Jan 29, 2025 | 2.19 | +0.92 |
Ellington Financial | 1EL0 | Jan 29, 2025 | 21.00 | +0.96 |
Ellington Financial Inc. | 1EL | Jan 29, 2025 | 11.90 | -1.65 |
Ellington Residential Mortgage REIT | 73Z | Jan 29, 2025 | 6.30 | 0.00 |
Elliptic Laboratories | EIP | Jan 29, 2025 | 0.89 | +1.59 |
Ellwee | 9U20 | Jan 29, 2025 | 0.16 | +4.70 |
Elmos Semiconductor SE | ELG | Jan 29, 2025 | 71.10 | -1.80 |
ELOP | 72G | Jan 29, 2025 | 0.20 | +4.24 |
Elopak ASA | 9J7 | Jan 29, 2025 | 3.52 | -0.57 |
Eloro Resources Ltd | P2QM | Jan 29, 2025 | 0.72 | +2.85 |
Elq S.A. | 7DP | Jan 29, 2025 | 0.62 | -0.32 |
Elringklinger AG | ZIL2 | Jan 29, 2025 | 4.85 | +2.86 |
ElringKlinger AG American Depositary Receipts - Unsponsored | ZIL | Jan 29, 2025 | 2.26 | +2.73 |
ELSA SOLUTIONS S.P.A. | 7TX | Jan 29, 2025 | 2.02 | +1.51 |
Else Nutrition Holdings Inc | 0YL | Jan 29, 2025 | 0.00 | 0.00 |
Eltel | E5E | Jan 29, 2025 | 0.52 | +0.78 |
ELTON S.A. NAM. EO 0,52 | Y1O | Jan 29, 2025 | 1.73 | +0.23 |
Elumeo SE | ELB | Jan 29, 2025 | 2.04 | 0.00 |
ELVALHALCOR NA EO 0,39 | HC6A | Jan 29, 2025 | 2.00 | +1.52 |
Elysee Development Corp. | QLDN | Jan 29, 2025 | 0.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.